A publicly traded South Florida company is accused of trying to capitalize on the COVID-19 pandemic with false promises of a huge N95 mask supply line and setting the minimum order at 100,000 masks.

West Palm Beach-based Praxsyn Corp. issued misleading mask promotions dating back to at least Feb. 27 when the virus was mostly an Asian phenomenon and the United States had 15 cases, the Securities and Exchange Commission charged Tuesday.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]